tm
Seeing Is Believing
tm
Seeing Is Believing
Vyne Therapeutics's activity chart (see below) currently has 29 price targets and 26 ratings on display.
Analysts average stock forecasts to be materialized ratio is 68.33% with an average time for these price targets to be met of 380.5 days.
Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 30-Jul-2025. First documented stock forecast 06-Sep-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-May-2022
$4.5
1 years 1 months 17 days ago
(30-Jul-2025)
21/21 (100%)
$3.06 (212.50%)
643
Buy Since 03-Jul-2025
$5
$-25.45 (-83.58%)
$8
1 years 2 months 13 days ago
(03-Jul-2025)
2/2 (100%)
$3.57 (249.65%)
503
Buy
$9
$7.54 (516.44%)
3 years 4 months 3 days ago
(12-May-2023)
1/3 (33.33%)
$1.77 (24.48%)
346
Buy
4 years 1 months 5 days ago
(10-Aug-2022)
2/5 (40%)
$123.12 (95.53%)
30
What is VYNE (Vyne Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on VYNE (Vyne Therapeutics)?
Which analyst has the current lower performing score on VYNE (Vyne Therapeutics) with a proven track record?
Which analyst has the most public recommendations on VYNE (Vyne Therapeutics)?
Which analyst is the currently most bullish on VYNE (Vyne Therapeutics)?
Which analyst is the currently most reserved on VYNE (Vyne Therapeutics)?
